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David was my first Ph.D. student, joining my newly
established lab in 1966 at the Hebrew University—
Hadassah Medical School in Jerusalem. He was accepted
at that time to the Medical School, after spending 1 year as
a student in another Faculty. David was born in Morocco
and immigrated to Israel with his family in 1956. The
family settled in a small village and David had to commute
daily to attend school. After serving the mandatory tour of
duty in the Israeli military, he came to the Hebrew
University, determined to attend the medical school, despite
the many hurdles he had to overcome. David loved
scientific research and at that early phase in his career he
was already fully committed to becoming a physician-
scientist, and getting a Ph.D. along with his M.D. degree
was an obvious approach. It was a pleasure having him in
the lab, a young man full of enthusiasm, original thinking,
and fantastic dexterity and capacity to perform at the bench.
We quickly established a close friendship and David
became a part of my family. After completing his Ph.D.
in 1969, he established an immunology lab in the
Department of Oncology at Hadassah Hospital, but lucky for
all of us, he then met and married Judy, the daughter
of Professor Michaelson, the renowned ophthalmologist.
Professor Michaelson introduced David to the exciting world
of ophthalmology and David shifted his enthusiasm and
scientific curiosity to learn about the wonders of the eye.
After completing his residency in ophthalmology, David
was sent by the State of Israel and Hadassah Hospital, to
help patients with eye diseases in Ethiopia and Malawi.
After returning to Jerusalem, he was invited by Dr. Carl
Kupfer, the founder of the National Eye Institute (NEI),
with a mission to establish a new lab dealing with ocular
immunology. David then contacted me with a suggestion to
join the NEI, as an immunologist in the new lab he
established. I accepted the offer and David introduced me
to the amazing organ, the eye, a decade after I introduced
him to the exciting world of immunology. Once again,
David and I could collaborate and keep being in touch
continuously; particularly during a sabbatical he spent at
the NEI, the annual ARVO, and other meetings.
Back at the Hadassah Hospital, David focused his
clinical efforts on pediatric ophthalmology. He founded a
clinical Unit and established a lab where he could carry out
research related to his clinical activities and other scientific
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excited about dealt with angiogenesis, a process that
received little attention at that time, but its importance for
ophthalmology was realized by Professor Michaelson, who
hypothesized then that the angiogenic process is mediated
by a molecule he named “Factor X”. David took over this
study, developing new methods to dissect the process and
analyzing a large number of compounds for their capacity
to inhibit angiogenesis. Decades later, “Factor X,” was
identified to be “VEGF”, a molecule that is currently the
target of successful therapies of major eye diseases. Other
studies David carried out had dealt with a wide range of
topics that included uveitis and the involvement of
inflammation in eye diseases, immunosuppressive agents,
drug delivery, unique issues of pediatric ophthalmology, as
well as genetics of eye disease. More recently, David
collaborated with Francine Behar-Cohen, developing novel
molecular biology approaches for treatment of eye disease.
David was an outstanding ophthalmologist, excelling in
ocular surgery, an area in which he often challenged
traditional concepts and introduced innovative ideas. He
saved vision of a countless number of patients, mostly
children. His reputation attracted patients from all over
Israel, as well as other countries in the Middle East. He was
devoted to his patients and their families and his office
walls were covered with their letters of appreciation.
David’s achievements were well recognized by the
ophthalmological community. He was invited to serve as a
Professor at the Universities and Hospitals in Paris and as a
Visiting Professor in several universities in Europe and the
USA and as a keynote speaker in numerous meetings
around the globe. He received several major scientific
awards, including the Alcon Research Award (1988). He
served on the editorial boards of five journals and was the
author of five books, more than 200 peer-reviewed articles,
and a number of chapters in books.
David devoted much of his time and energy to promote
international sharing of knowledge and information on
ophthalmology and vision research. He conceived the idea
of an international organization that would unite ophthal-
mologists and vision scientists, and together with Jorge
Alio, he founded the International Ocular Inflammation
Society (IOIS), as described below in detail by Jorge. Other
major achievements have been the convening of the
Michaelson symposia on ocular circulation and neovascu-
larization and being the Chairman and the organizer of five
international panels of experts who authored the guidelines
for diagnosis and treatment of major eye conditions.
David’s contributions were recognized by having him
elected to the Presidency of IOIS (1992–1998) and the
Mediterranean Ophthalmological Society (1998–2000), as
well as membership on numerous international scientific
committees.
David BenEzra and the creation of the International
Ocular Inflammation Society
The idea of starting the international symposium on ocular
inflammation occurred in a meeting that took place between
Jorge Alio and David BenEzra in 1989, during the initial
launch of the use of cyclosporine in ophthalmology. Jorge
and David met there for the first time and this marked the
beginning of a longstanding friendship. At that time, the
launch of cyclosporine A in Spain and the new topical anti-
inflammatory non-steroidal medications created a space, in
the opinion of Jorge, for an international meeting in which
the use of new pharmacological agents and a comprehen-
sive review of the issues related to immunology, inflam-
mation, and ophthalmology could take place. With these
ideas, the first international symposium on ocular inflam-
mation was organized in Alicante in 1990 (Fig. 1 shows the
cover page of that meeting). The meeting was a great
success with over 250 participants and important interac-
tions with the pharmacological industry. A decision was
made to organize a second symposium 2 years later in
Jerusalem. The meeting in Jerusalem was an even greater
success with over 400 participants, a very fruitful scientific
program and the creation of a scientific committee. (Fig. 2
shows the cover page of the meeting in Jerusalem). The
Fig. 1 The cover page of the
first international symposium on
ocular inflammation organized
in Alicante in 1990
Fig. 2 The cover page of the
second international symposium
on ocular inflammation
organized in Jerusalem in 1992
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the meeting and a decision was made to go ahead with it.
The leaders of the society were as follows: David BenEzra,
President; Jorge Alio, Chairman; Manabu Mochizuki,
General Secretary; Christian de Courten, Treasurer. The
society was named IOIS and was created as a charity
institution in Spain, with a global projection, bylaws, and
with a journal, the Ocular Immunology and Inflammation
(OII).
Since then, IOIS meetings have been organized every
2 years, in Fukuoka (1994), London (1996), Amsterdam
(1998), Istanbul (2000), Padova (2003), Granada (2005),
Paris (2007), and Prague (2009). The IOIS currently has
768 members, from 50 countries and has organized 10
international symposia. The upcoming symposium will take
place in Goa, India, in November 2011. Eventually, the
partnership with the publisher of the OII journal was
discontinued due to certain disagreements. The idea to
create a new journal for the Society was on the minds of
David and the other leaders of the Society and the decision
to do it was made during the Prague symposium, with the
new journal being named the Journal of Ophthalmic
Inflammation and Infection. It is just to demonstrate that
destiny exists that this obituary is published in the first
issue of the new journal of the IOIS, so beloved by David
BenEzra.
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